1. Home
  2. OLMA vs BVS Comparison

OLMA vs BVS Comparison

Compare OLMA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

N/A

Current Price

$7.20

Market Cap

949.3M

Sector

Health Care

ML Signal

N/A

Logo Bioventus Inc.

BVS

Bioventus Inc.

N/A

Current Price

$10.68

Market Cap

910.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OLMA
BVS
Founded
2006
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
949.3M
910.2M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
OLMA
BVS
Price
$7.20
$10.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
5
Target Price
★ $35.50
$16.60
AVG Volume (30 Days)
★ 1.4M
613.2K
Earning Date
11-10-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
15.00
★ 163.46
EPS
N/A
★ 0.60
Revenue
N/A
★ $568,087,000.00
Revenue This Year
N/A
$4.72
Revenue Next Year
N/A
$6.41
P/E Ratio
★ N/A
$17.68
Revenue Growth
★ N/A
N/A
52 Week Low
$6.24
$6.47
52 Week High
$36.26
$15.89

Technical Indicators

Market Signals
Indicator
OLMA
BVS
Relative Strength Index (RSI) 46.14 34.26
Support Level $6.47 $8.21
Resistance Level $7.61 $11.00
Average True Range (ATR) 0.59 0.67
MACD 0.07 -0.13
Stochastic Oscillator 30.43 12.37

Price Performance

Historical Comparison
OLMA
BVS

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: